drugset
drugset / Trial / NCT00089687

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

NCT00089687 ↗

Phase 1 Unknown 10 enrolled National Institute on Drug Abuse (NIDA)
Treatment

Summary

The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.

Timeline

Start
2004-04
Primary completion
—
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject vanoxerine Small molecule 75 mg —

Indications

substance-related disorder